Carol A. Gloff
Plus aucun poste en cours
Profil
Carol A.
Gloff is the founder of Embera NeuroTherapeutics, Inc., which was founded in 2005.
She held the title of VP-Pre-Clinical Development & Regulatory Affairs.
Dr. Gloff also held former positions at Alkermes, Inc. and ImmunoGen, Inc. as Vice President-Regulatory Affairs.
Additionally, she worked at Triton Biosciences, Inc. as Manager-Pharmacokinetics & Toxicology.
Dr. Gloff received her undergraduate degree from the State University of New York at Buffalo and her graduate degree from The University of California, San Francisco.
Anciens postes connus de Carol A. Gloff
| Sociétés | Poste | Fin |
|---|---|---|
| Triton Biosciences, Inc. | Corporate Officer/Principal | - |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Conseiller Juridique Général | - |
| IMMUNOGEN, INC. | Conseiller Juridique Général | 24/08/2011 |
Embera NeuroTherapeutics, Inc.
 Embera NeuroTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Embera NeuroTherapeutics, Inc. develops treatments for smoking cessation, cocaine dependence and other addictions. The company was founded by Nicholas Edward Goeders and Marie A. Lindner in 2005 and is headquartered in Sudbury, MA. | Fondateur | - |
Formation de Carol A. Gloff
| State University of New York at Buffalo | Undergraduate Degree |
| The University of California, San Francisco | Graduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Embera NeuroTherapeutics, Inc.
Embera NeuroTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Embera NeuroTherapeutics, Inc. develops treatments for smoking cessation, cocaine dependence and other addictions. The company was founded by Nicholas Edward Goeders and Marie A. Lindner in 2005 and is headquartered in Sudbury, MA. | Health Technology |
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Health Technology |
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. | Health Technology |
| Triton Biosciences, Inc. |
